Stonegate Investment Group’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-893
Closed -$283K – 414
2024
Q3
$283K Buy
893
+303
+51% +$108K 0.01% 284
2024
Q2
$221K Buy
+590
New +$199K 0.01% 323
2024
Q1
– Sell
-7,162
Closed -$3.28M – 374
2023
Q4
$3.28M Sell
7,162
-25
-0.3% -$12.3K 0.11% 82
2023
Q3
$3.5M Sell
7,187
-100
-1% -$47K 0.13% 78
2023
Q2
$3.26M Buy
7,287
+1,110
+18% +$559K 0.12% 83
2023
Q1
$3M Buy
6,177
+1,337
+28% +$661K 0.11% 87
2022
Q4
$2.48M Sell
4,840
-30
-0.6% -$15.8K 0.11% 90
2022
Q3
$2.36M Buy
4,870
+923
+23% +$449K 0.11% 99
2022
Q2
$1.85M Buy
3,947
+913
+30% +$406K 0.08% 112
2022
Q1
$1.32M Buy
+3,034
New +$1.27M 0.04% 117

Other funds holding HUM

Stonegate Investment Group's HUM Position: Q4 2024 in Review

Stonegate Investment Group sold out of Humana (HUM) in Q4 2024, closing a stake of 893 shares — an estimated $283K sold.

Stonegate Investment Group first reported a position in HUM in Q1 2022 and held it in 10 quarters. The position peaked at $3.5M in Q3 2023. 879 funds tracked by Wall St. Rank hold HUM as of Q4 2024.

  • Stonegate Investment Group reported no remaining Humana position as of Q4 2024 after selling out during the quarter.
  • Stonegate Investment Group sold 893 Humana shares in Q4 2024, an estimated $283K.
  • Stonegate Investment Group first reported a position in Humana in Q1 2022 and held it in 10 quarters.
  • Stonegate Investment Group's Humana position peaked at $3.5M in Q3 2023.
  • 879 funds tracked by Wall St. Rank held Humana as of Q4 2024.

Based on Stonegate Investment Group's 13F filing for Q4 2024, filed 22 Jan 2025.